Abstract:Background: Primary hepatocellular carcinoma (HCC) is a common malignant tumour, and its early symptoms are often not obvious, resulting in many patients experiencing middle- to late-stage disease at the time of diagnosis. The optimal time for surgery is often missed for these patients, and those who do undergo surgery have unsatisfactory long-term outcomes and a high recurrence rate within five years. Therefore, postoperative follow-up treatments, such as transhepatic arterial chemoembolization (TACE), have become critical to improving survival and reducing recurrence rates. Aim: To validate the prophylactic role of TACE after hepatic resection and to assess its impact on patient prognosis. Methods: This study investigated the efficacy of TACE in patients with intermediate-stage HCC after hepatectomy. When the post-treatment results of the observation group and the control group were compared, it was found that the inclusion of TACE significantly improved the clinical efficacy, reduced the levels of tumour markers and did not aggravate the damage to liver function. Thus, this may be an effective and comprehensive treatment strategy for patients with intermediate-stage HCC that helps to improve their quality of life and survival time. Results: When the baseline data were analysed, no statistical differences were found between the two groups in terms of gender, age, hepatitis B virus, cirrhosis, Child-Pugh grading, number of tumours, maximum tumour diameter and degree of tumour differentiation. The assessment of clinical efficacy showed that the post-treatment overall remission rate of the observation group was significantly higher than that of the control group. In terms of changes in tumour markers, the alpha-fetoprotein and carcinoembryonic antigen levels in the patients in the observation group decreased more significantly after treatment compared with those in the control group. When post-treatment changes in liver function indicators were analysed, no statistical differences were found in the total bilirubin, alanine aminotransferase and aspartate aminotransferase levels between the two groups. Conclusion: In patients with intermediate-stage HCC, post-hepatectomy TACE significantly improved clinical outcomes, reduced tumour-marker levels and may have improved the prognosis by removing residual lesions. Thus, this may be an effective and comprehensive treatment strategy for patients with intermediate-stage HCC.

Protective Effects of S-adenosylmethionine on Liver Function in HCC Patients after Liver Resection

Clinical effect of S-adenosylmethionine on patients with hepatocellular carcinoma resection

The effect of intraoperative administration of S-adenosy-methionine on remnant liver function and regeneration after left lobe resection

Beneficial Effects of S-adenosyl-L-methionine on Post-Hepatectomy Residual Liver Function: a Prospective, Randomized, Controlled Clinical Trial.

PROTECTIVE EFFECTS OF S-ADENOSYL-L-METHIONINE ON POST-HEPATECTOMY LIVER FUNCTION

Protective effect of S-adenosylmethionine on hepatic ischemia-reperfusion injury during hepatectomy in HCC patients with chronic HBV infection

The Effect of S-adenomethionine on Early Stage Recovery of Transplanted Liver Function

Prospective, randomized and controlled trial study on protective effects of S-adenosylmethionine (enteric-coated tablets) on liver function after transcatheter arterial chemoembolization (TACE)

Effects of HGF and SAM on Liver Regeneration and Liver Function in Cirrhotic Rats after Hepatectomy

Effect of Hepatitis on Surgical Treatment and Prognosis of Colorectal Liver Metastasis

Preventive Effect of S-adenosyl-L-methionine from Alcoholic Liver Injury in Rats

Hepatic Resection for Hepatocellular Carcinoma with or Without Postoperative Adjuvant Transarterial Chemoembolization: a Comparative Study

Impact of hepatectomy and postoperative adjuvant transarterial chemoembolization on serum tumor markers and prognosis in intermediate-stage hepatocellular carcinoma

Comparative Study on Therapeutic Effect Between Anatomical Liver Resection and Nonanatomical Liver Resection for Hepatocellular Carcinoma Patients

Impact of Liver Function During Perioperative Period on Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma

Therapeutic Effects of Hepatic Resection in Liver Metastasis of Colorectal Cancer

Clinical study of S-adenosyl-L-methionine in the treatment of malignant obstructive jaundice after surgical drainage

Changes of Oxidative Stress, Glutathione, and Its Dependent Antioxidant Enzyme Activities in Patients with Hepatocellular Carcinoma before and after Tumor Resection

The Protective Effect of S-adenosylmethionine on Liver Ischemia Reperfusion Injury in Rats

Effect of L-ornithine-L-aspartate on Liver Fuction after Hemihepatectomy in Patients with Hepatocel-lular Carcinoma and Liver Cirrhosis

Hepatic Histopathology and Postoperative Outcome after Preoperative Chemotherapy for Chinese Patients with Colorectal Liver Metastases.